Respiratory Medicine
Volume 104, Issue 4 , Pages 473-480 , April 2010

Association between polymorphism of glutathione S-transferase P1 and chronic obstructive pulmonary disease: A meta-analysis

  • Fugui Yan

      Affiliations

    • Department of Respiratory Medicine, First Affiliated Hospital, Wenzhou Medical College, Wenzhou, PR China
    • ,
  • Chengshui Chen

      Affiliations

    • Department of Respiratory Medicine, First Affiliated Hospital, Wenzhou Medical College, Wenzhou, PR China
    • Corresponding Author InformationCorresponding authors.
    • ,
  • Jiyong Jing

      Affiliations

    • Department of Respiratory Medicine, Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University Institute of Respiratory Diseases, Hangzhou, PR China
    • ,
  • Wen Li

      Affiliations

    • Department of Respiratory Medicine, Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University Institute of Respiratory Diseases, Hangzhou, PR China
    • ,
  • Huahao Shen

      Affiliations

    • Department of Respiratory Medicine, Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University Institute of Respiratory Diseases, Hangzhou, PR China
    • ,
  • Xiangdong Wang

      Affiliations

    • Department of Respiratory Medicine and Biomedical Research Center, Zhongshan Hospital, Fudan University, Shanghai, PR China
    • Corresponding Author InformationCorresponding authors.

Received 15 January 2009 ,Accepted 10 January 2010.

References 

  1. Calverley PM, Walker P. Chronic obstruct105Ile/vale pulmonary disease. Lancet. 2003;362:1053–1061
  2. Lopez AD, Murray CC. The global burden of disease, 1990–2020. Nat Med. 1998;4:1241–1243
  3. Lokke A, Lange P, Scharling H, et al. Developing COPD: a 25-year follow-up study of the general population. Thorax. 2006;61:935–939
  4. Cantlay AM, Smith CA, Wallace WA. Heterogeneous expression and polymorphic genotype of glutathione S-transferases in human lung. Thorax. 1994;49:1010–1014
  5. Calikoglu M, Tamer L, Ates Aras N, et al. The association between polymorphic genotypes of glutathione S-transferases and COPD in the Turkish population. Biochem Genet. 2006;44:307–319
  6. Rodriguez F, Roza dela C, Jardi R, et al. Glutathione S-transferase P1 and lung function in patients with alpha1-antitrypsin deficiency and COPD. Chest. 2005;127:1537–1543
  7. Xiao D, Wang C, Du MJ, et al. Relationship between polymorphisms of genes encoding microsomal epoxide hydrolase and glutathione S-transferase P1 and chronic obstruct105Ile/Vale pulmonary disease. Chin Med J Engl. 2004;117:661–667
  8. Gaspar P, Moreira J, Kvitko K, et al. CYP1A1, CYP2E1, GSTM1, GSTT1, GSTP1, and TP53 polymorphisms: do they indicate susceptibility to chronic obstruct105Ile/Vale pulmonary disease and non-small-cell lung cancer?. Genet Mol Biol. 2004;27:133–138
  9. Cheng SL, Yu CJ, Chen CJ, et al. Genetic polymorphism of epoxide hydrolase and glutathione S-transferase in COPD. Eur Respir J. 2004;23:818–824
  10. Vibhuti A, Arif E, Deepak D, et al. Genetic polymorphisms of GSTP1 and mEPHX correlate with oxidat105Ile/Vale stress markers and lung function in COPD. Biochem Biophys Res Commun. 2007;359:136–142
  11. Yim JJ, Yoo CG, Lee CT, et al. Lack of association between glutathione S-transferase P1 polymorphism and COPD in Koreans. Lung. 2002;180:119–125
  12. Lu B, He Q. Correlation between exon5 polymorphism of glutathione S-transferase P1 gene and susceptibility to chronic obstruct105Ile/Vale pulmonary disease in northern Chinese population of Han nationality l105Ile/Valing in Beijing, China. Zhonghua Nei Ke Za Zhi. 2002;41:678–681
  13. Chan-Yeung M, Ho SP, Cheung AH, et al. Polymorphisms of glutathione S-transferase genes and functional act105Ile/Vality in smokers with or without COPD. Int J Tuberc Lung Dis. 2007;11:508–514
  14. Ishii T, Matsuse T, Teramoto S, et al. Glutathione S-transferase P1 (GSTP1) polymorphism in patients with chronic obstruct105Ile/Vale pulmonary disease. Thorax. 1999;54:693–696
  15. Harries LW, Stubbins MJ, Forman D, et al. Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis. 1997;18:641–644
  16. Xiao D, Wang C, Du MJ, et al. Association between polymorphisms in the gene coding for glutathione S-transferase P1 and chronic obstruct105Ile/Vale pulmonary disease. Zhonghua Jie He He Hu Xi Za Zhi. 2003;26:555–558
  17. He JQ, Connett JE, Anthonisen NR, et al. Glutathione S-transferase variants and their interaction with smoking on lung function. Am J Respir Crit Care Med. 2004;170:388–394
  18. Gilliland FD, Gauderman WJ, Vora H, et al. Effects of glutathione-S-transferase M1, T1, and P1 on childhood lung function growth. Am J Respir Crit Care Med. 2002;166:710–716
  19. Woolf B. On estimating the relationship between blood group and disease. Ann Hum Genet. 1955;19:251–253
  20. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088–1101
  21. Egger M, Davey SG, Schneider M. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–634
  22. Egger M, Davey SG. Misleading meta-analysis. BMJ. 1995;310:752–754
  23. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–1558
  24. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–560
  25. Lohmueller KE, Pearce CL, Pike M. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet. 2003;33:177–182
  26. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retro-spect105Ile/Vale studies of disease. J Natl Cancer Inst. 1959;22:719–748
  27. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clin Trials. 1986;7:177–188
  28. Morita S, Yano M, Tsujinaka T. Association between genetic polymorphisms of glutathione S-transferase P1 and N-acetyltransferase 2 and susceptibility to squamous-cell carcinoma of esophagus. Int J Cancer. 1998;79:517–520
  29. Katoh T, Kaneko S, Takasawa S. Human glutathione-Stransferase P1 polymorphism and susceptibility to smoking related epithelial cancer; oral, lung, gastric, colorectal and urothelial cancer. Pharmacogenetics. 1999;9:165–169
  30. Sundberg K, Johansson AS, Stenberg G. Differences in the catalytic efficiencies of allelic variants of glutathione transferase P1 towards carcinogenesis diol epoxides of polycyclic aromatic hydrocarbons. Carcinogenesis. 1998;19:433–436
  31. Hu X, O'Donnell R. Sr105Ile/Valastava SK. Act105Ile/Vale site architecture of polymorphic forms of human glutathione S-transferase P1-1 accounts for their enantioselect105Ile/Vality and disparate act105Ile/Vality in the glutathione conjugation of 7beta, 8alpha-dihydroxy-9alpha,10alpha-oxy-7,8,9,10-tetrahydrobenzo(a)pyrene. Biochem Biophys Res Commun. 1997;235:424–428
  32. Zimniak P, Nandur B, Pikula S. Naturally occurring human glutathione S-transferase GSTP-1 isoforms with isoleucine and valine in position 104 differ in enzymatic properties. Eur J Biochem. 1994;224:893–899
  33. Watson MA, Stewart RK, Smith GB. Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme act105Ile/Vality and population frequency distribution. Carcinogenesis. 1998;19:275–280

PII: S0954-6111(10)00016-8

doi: 10.1016/j.rmed.2010.01.009

Respiratory Medicine
Volume 104, Issue 4 , Pages 473-480 , April 2010

Article Tools

* Image Usage & Resolution